Inhibitor-resistant TEM -lactamases: phenotypic, genetic and biochemical characteristics
Open Access
- 1 April 1999
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 43 (4) , 447-458
- https://doi.org/10.1093/jac/43.4.447
Abstract
β-Lactamases represent the main mechanism of bacterial resistance to β -lactam antibiotics. The recent emergence of bacterial strains producing inhibitor-resistant TEM (IRT) enzymes could be related to the frequent use of β-lactamase inhibitors such as clavulanic acid, sulbactam and tazobactam in hospitals and in general practice. The IRT β -lactamases differ from the parental enzymes TEM-1 or TEM-2 by one, two or three amino acid substitutions at different locations. This paper reviews the phenotypic, genetic and biochemical characteristics of IRT β-lactamases in an attempt to shed light on the pressures that have contributed to their emergence.Keywords
This publication has 60 references indexed in Scilit:
- Molecular Diversity and Evolution of bla TEM Genes Encoding β-Lactamases Resistant to Clavulanic Acid in Clinical E. coliJournal of Molecular Evolution, 1997
- Characterization of an inhibitor-resistant enzyme IRT-2 derived from TEM-2 β-lactamase produced by Proteus mirabilis strainsJournal of Antimicrobial Chemotherapy, 1996
- Mechanisms of hyperproduction of TEM-1 β-lactamase by clinical isolates of Escherichia coliJournal of Antimicrobial Chemotherapy, 1995
- Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM beta-lactamases from clinical isolates of Escherichia coliAntimicrobial Agents and Chemotherapy, 1995
- Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 beta-lactamase conferring resistance to beta-lactamase inhibitorsAntimicrobial Agents and Chemotherapy, 1994
- Effect of hyperproduction of TEM-1 beta-lactamase on in vitro susceptibility of Escherichia coli to beta-lactam antibioticsAntimicrobial Agents and Chemotherapy, 1994
- Clinical isolates of Escherichia coli producing TRI β-lactamases: novel TEM-enzymes conferring resistance to β-lactamase inhibitorsJournal of Antimicrobial Chemotherapy, 1992
- Factors determining resistance to β-lactam combined with β-lactamase inhibitors in Escherichia coliJournal of Antimicrobial Chemotherapy, 1991
- Small plasmids are involved in amoxicillin-clavulanate resistance in Escherichia coliAntimicrobial Agents and Chemotherapy, 1989
- Beta-lactam resistance in clinical isolates of Escherichia coli caused by elevated production of the ampC-mediated chromosomal beta-lactamaseAntimicrobial Agents and Chemotherapy, 1979